Telitacicept in myasthenia gravis: a systematic review of clinical outcomes, steroid-sparing effects, and safety.

Zhang W, Wang Y, Qiao W

Open source

DOI
10.3389/fneur.2026.1916224
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1916224,
  title = {Telitacicept in myasthenia gravis: a systematic review of clinical outcomes, steroid-sparing effects, and safety.},
  author = {Zhang W and Wang Y and Qiao W},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1916224},
  url = {https://doi.org/10.3389/fneur.2026.1916224}
}

RIS

TY  - JOUR
TI  - Telitacicept in myasthenia gravis: a systematic review of clinical outcomes, steroid-sparing effects, and safety.
AU  - Zhang W
AU  - Wang Y
AU  - Qiao W
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1916224
UR  - https://doi.org/10.3389/fneur.2026.1916224
ER  - 

APA

W, Z., Y, W., & W, Q. (2026). Telitacicept in myasthenia gravis: a systematic review of clinical outcomes, steroid-sparing effects, and safety.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1916224

Source records